Pharmaceutical Product Development’s Senior Secured Credit Facilities
August 20, 2015
On August 18, 2015, Pharmaceutical Product Development, LLC (“PPD”), a leading global contract research organization providing drug discovery, development, lifecycle management and laboratory services, closed a dividend recapitalization transaction. Cravath represented Credit Suisse as lead arranger in connection with the arrangement of $2.875 billion of senior secured credit facilities. PPD is a portfolio company of The Carlye Group and Hellman & Friedman.
The Cravath team included partner Joseph D. Zavaglia and associates Matthew G. Jones and Sean M. Gholz. Summer associate Nathan H. Trunnell also worked on this matter.
Related Practices & Industries
People
- Photo
-
-
J.D., 2004, Brooklyn Law SchoolValedictorian, summa cum laude
-
B.B.A., 2001, College of Insurancecum laude
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
July 23, 2026
Nexeye’s Repricing of its Term Loan Facility
Cravath represented the arrangers in connection with the repricing of Nexeye Holding B.V.’s €325 million term loan facility. Nexeye Holding B.V., a portfolio company of KKR, is a leading European optical retailer. The transaction closed on June 9, 2026.
Deals & Cases
July 13, 2026
Boluda Towage’s €2.45 Billion Term Loan and Revolving Credit Facilities
Cravath represented the agent, mandated lead arrangers and lenders in connection with Boluda Towage’s €2.15 billion (equivalent) term loan facility and €300 million multi‑currency revolving credit facility. The proceeds will be used towards refinancing certain existing credit facilities and for general corporate purposes. Boluda Towage is a leading maritime services operator. The transaction closed on June 30, 2026.
Deals & Cases
July 06, 2026
UVEX’s Upsize and Repricing of its Term Loan Facility
Cravath represented the agent, mandated lead arrangers, and lenders in connection with the repricing of UVEX GROUP GmbH’s €400 million term loan facility and €50 million term loan add-on. UVEX GROUP GmbH is a portfolio company of Warburg Pincus. The transaction closed on June 19, 2026.
Deals & Cases
April 06, 2026
Versigent’s $1.35 Billion Credit Facilities and $1.6 Billion High‑Yield Senior Notes Offering in Connection with Aptiv PLC’s Spin‑Off of Versigent
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $1.35 billion of credit facilities made available to subsidiaries of Versigent Limited, a global leader in the design, development and manufacture of low voltage and high voltage electrical architectures and the holding company for Aptiv PLC’s Electrical Distribution Systems segment, which Aptiv PLC spun off into a separate, independent, publicly traded company. The proceeds were used to partially finance the spin‑off. The credit facilities consisted of a $500 million term loan facility and an $850 million revolving credit facility. The transaction closed on November 26, 2025.
